Deferred cytoreductive nephrectomy among patients with newly diagnosed metastatic renal cell carcinoma treated initially with sunitinib.

被引：0
|
作者：
Bhindi, Bimal
Graham, Jeffrey
Wells, Connor
Donskov, Frede
Pasini, Felice
Lee, Jae-Lyun
Basappa, Naveen S.
Hansen, Aaron Richard
Wood, Lori
Kollmannsberger, Christian K.
Kanesvaran, Ravindran
Yuasa, Takeshi
Ernst, D. Scott
Srinivas, Sandy
Rini, Brian I.
Bowman, I. Alex
Pal, Sumanta K.
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[5] S Maria della Misericordia Hosp, Dept Oncol, ULSS 18, Rovigo, Italy
[6] Asan Med Ctr, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Seoul, South Korea
[8] Cleveland Clin, Cleveland, OH 44106 USA
[9] Princess Margaret Canc Ctr, Toronto, ON, Canada
[10] Dalhousie Univ, Halifax, NS, Canada
[11] BC Canc Vancouver Canc Ctr, Vancouver, BC, Canada
[12] Natl Canc Ctr Singapore, Singapore, Singapore
[13] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[14] London Hlth Sci Ctr, London Reg Canc Program, Dept Oncol, Div Med Oncol, London, ON, Canada
[15] Univ Western Ontario, London, ON, Canada
[16] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[18] UT Southwestern Med Ctr, Dallas, TX USA
[19] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[20] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[21] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4578
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Influence of risk factors for renal cell carcinoma (RCC) on outcome of patients (pts) with metastatic disease treated with sunitinib.
    Keizman, Daniel
    Ish-Shalom, Maya
    Taksey, Jason David
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Boursi, Ben
    Berger, Raanan
    Maimon, Natalie
    Gottfried, Maya
    Hayat, Henry
    Peer, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [22] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song Yan
    Du Chun-Xia
    Zhang Wen
    Sun Yong-Kun
    Yang Lin
    Cui Cheng-Xu
    Chi Yihe-Bali
    Shou Jian-Zhong
    Zhou Ai-Ping
    Li Chang-Ling
    Ma Jian-Hui
    Wang Jin-Wan
    Sun Yan
    中华医学杂志英文版, 2016, 129 (05) : 530 - 535
  • [23] Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Tamboli, P.
    Patel, K. K.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1048 - 1053
  • [24] TARIBO trial: Cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with targeted agents
    Grassi, Paolo
    Verzoni, Elena
    Bearz, Alessandra
    Bracarda, Sergio
    Bregni, Marco
    Buti, Sebastiano
    Cinieri, Saverio
    De Giorgi, Ugo
    Fornarini, Giuseppe
    Galli, Luca
    Milella, Michele
    Morelli, Franco
    Nole, Franco
    Passalacqua, Rodolfo
    Sabbatini, Roberto
    Santini, Daniele
    Salvioni, Roberto
    Cappelletti, Vera
    Ratta, Raffaele
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song, Yan
    Du, Chun-Xia
    Zhang, Wen
    Sun, Yong-Kun
    Yang, Lin
    Cui, Cheng-Xu
    Chi, Yihe-Bali
    Shou, Jian-Zhong
    Zhou, Ai-Ping
    Li, Chang-Ling
    Ma, Jian-Hui
    Wang, Jin-Wan
    Sun, Yan
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 530 - 535
  • [26] Sunitinib Prior to Planned Cytoreductive Nephrectomy: Is This the New Litmus Test for Metastatic Renal Cell Carcinoma?
    Kim, Simon P.
    Thompson, R. Houston
    EUROPEAN UROLOGY, 2011, 60 (03) : 455 - 456
  • [27] Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
    Zequi, Stenio de C.
    INTERNATIONAL BRAZ J UROL, 2020, 46 (03): : 476 - 476
  • [28] Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial
    Minervini, Andrea
    Mari, Andrea
    Di Maida, Fabrizio
    Campi, Riccardo
    Carini, Marco
    Lapini, Alberto
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S208 - S210
  • [29] What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?
    Yanagisawa, Takafumi
    Schmidinger, Manuela
    Fajkovic, Harun
    Karakiewicz, Pierre I.
    Kimura, Takahiro
    Shariat, Shahrokh F.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (05) : 455 - 459
  • [30] Utilization of Partial Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma
    Hauser, Nicholas
    Giakas, Julian
    Robinson, Hunter
    Davaro, Facundo
    Hamilton, Zachary
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
12345